Denali Therapeutics, Inc. (DNLI)

18.64 -0.66 (-3.42%) USD  |  NASDAQ  |  May 22, 16:00
18.60 -0.04 (-0.21%) After-Hours: 20:00
More

Denali Therapeutics EPS Diluted (Quarterly) : -0.6882 for March 31, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Biogen, Inc. 2.153
Neurocrine Biosciences, Inc. 1.914
Arcturus Therapeutics Holdings, Inc. -0.9487
Agenus, Inc. 1.023
Curis, Inc. -1.250

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -128.45M
Total Expenses (Quarterly) 128.45M
Enterprise Value 2.011B
Earnings Yield -15.45%
Normalized Earnings Yield -15.45